John Vavricka

AVIR

John Vavricka serves as Chief Commercial Officer at Atea Pharmaceuticals, Inc. (AVIR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$129.7K

Net Position

Net Seller

$129.7K

Companies Traded

AVIR

Active Period

Jan 2024 – Jan 2026

3 total trades

Most Recent

Sell AVIR

Jan 31, 2026 · $49.1K

John Vavricka's Insider Trading at Atea Pharmaceuticals, Inc. (AVIR)

Buys

0 · $0.00

Sells

3 · $129.7K

Total Shares Bought

Total Shares Sold

34,906

AVIR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 31, 2026	Sell	11,570	$4.24	$49.1K
Jan 31, 2025	Sell	11,517	$3.06	$35.2K
Jan 31, 2024	Sell	11,819	$3.84	$45.4K

Related Insiders

Andrea Corcoran

See Remarks

AVIRSell · Jan 31, 2026

Wayne Foster

EVP, Chief Accounting Officer

AVIRSell · Jan 31, 2026

Janet MJ Hammond

Chief Development Officer

AVIRSell · Jan 31, 2026

Maria Arantxa Horga

Chief Medical Officer

AVIRSell · Jan 31, 2026

Jean-Pierre Sommadossi

President, CEO, and Chairman

AVIRSell · Jan 31, 2026

Explore More Insider Trading Data

AVIR Insider Trading Activity

View all insider trades at Atea Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity